Aurobindo Pharma gains on USFDA nod

The stock has jumped 2 percent at the opening bell on the BSE. The company has received USFDA approval for antiarrhythmic drug Flecainide Acetate.

Aurobindo Pharma opened 2 percent higher at Rs 1,480 on media reports that the company has received USFDA approval for antiarrhythmic drug Flecainide Acetate.

The stock is now up 1.3 percent at Rs. 1,469, with the counter has seen trades of around 10,000 shares as against two-week daily average volume of 102,000 shares.

Meanwhile, the Sensex has jumped 119 points at 27,692.